Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing-Reference-Cited by-同舟云学术

Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing

Published:2021-03 Issue:5 Volume:10 Page:
ISSN:2001-3078
Container-title:Journal of Extracellular Vesicles
language:en
Short-container-title:Journal of Extracellular Vesicles

Author:

Yao Xingang¹²,Lyu Pin¹,Yoo Kyung¹,Yadav Manish Kumar¹,Singh Ravi³,Atala Anthony¹,Lu Baisong¹

Affiliation:

1. Wake Forest Institute for Regenerative Medicine Wake Forest University Health Sciences Winston‐Salem North Carolina USA

2. State Key Laboratory of Organ Failure Research Guangdong Provincial Key Laboratory of New Drug Screening School of Pharmaceutical Sciences Southern Medical University Guangzhou P. R. China

3. Department of Cancer Biology Wake Forest University Health Sciences Winston‐Salem North Carolina USA

Publisher

Wiley

Subject

Cell Biology,Histology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jev2.12076

Reference42 articles.

1. High‐efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1‐based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G;Akkina R. K.;Journal of Virology,1996

2. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

3. Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus

4. Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein

5. CRISPResso2 provides accurate and rapid genome editing sequence analysis

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes as targeted diagnostic biomarkers: Recent studies and trends;Life Sciences;2024-10

2. Extracellular vesicles as drug delivery systems in therapeutics: current strategies and future challenges;Journal of Pharmaceutical Investigation;2024-09-02

3. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles;Frontiers in Immunology;2024-08-30

4. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment;eBioMedicine;2024-08

5. Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance;Biochemical Pharmacology;2024-08